Skip to main content
. 2014 Feb 15;7(3):1085–1092.

Figure 3.

Figure 3

Western blotting assay in HepG2 cells. ASH1L, C17ORF49 and SETD4 were silencing in HepG2 cells and treated with 5 μmol/L sorafenib or left untreated. 72 h later, cell lysates were subjected to SDS-PAGE and immunoblotted to 0.40 μm of PVDF membrane. And then, GAPDH, ERK, p-ERK, AKT and p-AKT were examined by antibodies.